Page 19 - Array Biopharma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Published: Mar 29, 2021   NEW YORK and PERTH, Australia, March 29, 2021 /PRNewswire/ -- PYC Therapeutics (ASX: PYC), a biotechnology company developing a new generation of precision RNA therapeutics to change the lives of patients with inherited diseases, today announced the appointment of Jason Haddock to its Board of Directors. Mr. Haddock brings more than two decades of financial, commercial and operational leadership experience in the biopharmaceutical industry, and currently serves as a Board Director of Codiak BioSciences, a biotech company developing precision exosome therapeutic...

Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results CGT9486 clinical trial initiations on-track: Advanced Systemic Mastocytosis (1H21), Non-Advanced Systemic Mastocytosis (2H21), Gastrointestinal Stromal Tumors (GIST) (2H21) Final data from CGT9486 + sunitinib Phase 1/2 study presented at CTOS 2020 demonstrated 12 months median PFS and 20% ORR, including a complete response, in heavily pre-treated advanced GIST patients. Randomized GIST clinical trial initiation expected in 2H21 Rapidly Growing with Several Key Additions to Management Team and Board of Director...

2020 Filings While there was a more than 20 percent decline in the number of securities class actions filed in 2020 (approximately 330 cases) as compared to 2019 (approximately 430 cases), the percentage of cases filed against life sciences companies remained steady at more than 20 percent of the total. 1 Only a half dozen of the new 2020 filings related to COVID-19. These statistics illustrate that life sciences companies remain attractive targets for securities class action plaintiffs. This is so for several reasons. The uncertainties facing drug and medical device companies are often binar...

Operator Good evening and welcome to Array Technologies fourth-quarter and full-year 2020 earnings conference call. Today's call is being recorded, and we have allocated one hour for prepared remarks and Q&A. At this time, I'd like to turn the call over to Cody Mueller, investor relations of Array Technologies. Thank you. You may begin. Investor Relations Good evening and thank you for joining us on today's conference call to discuss Array Technologies' fourth-quarter and full-year 2020 results. During this conference call, management will make forward-looking statements based on current expe...

Share this article Share this article ResearchAndMarkets.com's offering. The North America life science tools market size is expected to reach USD 81.9 billion by 2027 registering a CAGR of 11.6% The market growth is attributed to a rise in government funding for life science technologies, growth of cell & gene therapies, increasing demand for biopharmaceuticals, and a rise in competition among prominent market entities. Competitive dynamics continue to drive a rapid pace of innovation in sequencing, multiplex platforms, and major categories of mass spectrometry and liquid chromatography; th...